Similar articles for PMID: 10743925

Year	Number of Results
1963	1
1972	1
1977	1
1982	1
1983	1
1987	1
1988	1
1990	3
1991	1
1992	2
1993	4
1994	9
1995	3
1996	6
1997	6
1998	7
1999	5
2000	9
2001	7
2002	5
2003	4
2004	2
2005	7
2006	4
2007	3
2008	3
2009	1
2010	1
2011	1
2013	3
2014	3
2015	1
2018	1
2022	1

1

Threshold power levels for NPe6 photodynamic therapy.

Kazi AA, Peyman GA, Unal M, Khoobehi B, Yoneya S, Mori K, Moshfeghi D, Moshfeghi AA. Kazi AA, et al. Ophthalmic Surg Lasers. 2000 Mar-Apr;31(2):136-42. Ophthalmic Surg Lasers. 2000. PMID: 10743925

2

Angiographic and histologic effects of fundus photodynamic therapy with a hydrophilic sensitizer (mono-L-aspartyl chlorin e6).

Mori K, Yoneya S, Ohta M, Sano A, Anzai K, Peyman GA, Moshfeghi DM. Mori K, et al. Ophthalmology. 1999 Jul;106(7):1384-91. doi: 10.1016/S0161-6420(99)00729-0. Ophthalmology. 1999. PMID: 10406627

3

Threshold and retreatment parameters of NPe6 photodynamic therapy in retinal and choroidal vessels.

Peyman GA, Kazi AA, Moshfeghi D, Unal M, Khoobehi B, Yoneya S, Mori K, Rivera I. Peyman GA, et al. Ophthalmic Surg Lasers. 2000 Jul-Aug;31(4):323-7. Ophthalmic Surg Lasers. 2000. PMID: 10928670

4

Evaluation of the new photosensitizer Tookad (WST09) for photodynamic vessel occlusion of the choroidal tissue in rabbits.

Framme C, Sachs HG, Flucke B, Theisen-Kunde D, Birngruber R. Framme C, et al. Invest Ophthalmol Vis Sci. 2006 Dec;47(12):5437-46. doi: 10.1167/iovs.06-0532. Invest Ophthalmol Vis Sci. 2006. PMID: 17122134

5

PDT to monkey CNV with ATX-S10(Na): inappropriateness of early laser irradiation for selective occlusion.

Obana A, Gohto Y, Kaneda K, Nakajima S, Miki T. Obana A, et al. Invest Ophthalmol Vis Sci. 2001 Oct;42(11):2639-45. Invest Ophthalmol Vis Sci. 2001. PMID: 11581211

6

Photodynamic therapy of experimental choroidal neovascularization with a hydrophilic photosensitizer: mono-L-aspartyl chlorin e6.

Mori K, Yoneya S, Anzail K, Kabasawa S, Sodeyama T, Peyman GA, Moshfeghi DM. Mori K, et al. Retina. 2001;21(5):499-508. doi: 10.1097/00006982-200110000-00013. Retina. 2001. PMID: 11642380

7

Ocular vascular thrombosis following tin ethyl etiopurpurin (SnET2) photodynamic therapy: time dependencies.

Moshfeghi DM, Peyman GA, Moshfeghi AA, Khoobehi B, Primbs GB, Crean DH. Moshfeghi DM, et al. Ophthalmic Surg Lasers. 1998 Aug;29(8):663-8. Ophthalmic Surg Lasers. 1998. PMID: 9715492

8

Photodynamic therapy for choriocapillaris using tin ethyl etiopurpurin (SnET2).

Peyman GA, Moshfeghi DM, Moshfeghi A, Khoobehi B, Doiron DR, Primbs GB, Crean DH. Peyman GA, et al. Ophthalmic Surg Lasers. 1997 May;28(5):409-17. Ophthalmic Surg Lasers. 1997. PMID: 9150524

9

[Potential of photodynamic therapy with a second-generation sensitizer: mono-L-aspartyl chlorin e6].

Mori K, Ohta M, Sano A, Yoneya S, Sonoda M, Kaneda A, Sato Y. Mori K, et al. Nippon Ganka Gakkai Zasshi. 1997 Feb;101(2):134-40. Nippon Ganka Gakkai Zasshi. 1997. PMID: 9124093 Japanese.

10

Endovascular photodynamic therapy using mono-L-aspartyl-chlorin e6 to inhibit Intimal hyperplasia in balloon-injured rabbit arteries.

Nagae T, Aizawa K, Uchimura N, Tani D, Abe M, Fujishima K, Wilson SE, Ishimaru S. Nagae T, et al. Lasers Surg Med. 2001;28(4):381-8. doi: 10.1002/lsm.1066. Lasers Surg Med. 2001. PMID: 11344521

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed